Xtant Medical Holdings XTNT Stock-Based Comp
Stock-Based Comp at other companies
Other financials
Where this comes from
Reported directly by Xtant Medical Holdings in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensation.
The official record: Xtant Medical Holdings’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Xtant Medical Holdings's stock-based comp.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Xtant Medical Holdings's stock-based comp?
- Xtant Medical Holdings (XTNT) reported stock-based comp of $746K in Q1 2026.
- How has Xtant Medical Holdings's stock-based comp changed year-over-year?
- Xtant Medical Holdings's stock-based comp decreased by 1.6% year-over-year, from $758K to $746K.
- What is the long-term trend for Xtant Medical Holdings's stock-based comp?
- Over 4 years (2021 to 2025), Xtant Medical Holdings's stock-based comp has grown at a 6.9% compound annual growth rate (CAGR), from $2.21M to $2.89M.
- What does stock-based comp mean?
- Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.